Louise Goksøyr

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Gold Nanoparticles

Immune Response

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Azad Farzadfard, Jannik Nedergaard Pedersen, Georg Meisl, Arun Kumar Somavarapu, Parvez Alam, Louise Goksøyr, Morten Agertoug Nielsen, Adam Frederik Sander, Tuomas P J Knowles, Jan Skov Pedersen, Daniel Erik Otzen
The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization. Communications biology 5 (1) (2022)
Louise Goksøyr, Anders Boutrup Funch, Anna K Okholm, Thor G Theander, Willem Adriaan de Jongh, Charlotte M Bonefeld, Adam Frederik Sander
Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis. Vaccines 10 (5) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K Myeni, Robert Dagil, Christoph M Janitzek, Max Søgaard, Kara-Lee Aves, Emma W Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena Ethel Vidal-Calvo, Paul Khalifé, Thomas M Hulen, Swati Choudhary, Michael Theisen, Susheel K Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben P Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F Andersson, Soren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J Dalebout, Kasper Iversen, Lene H Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line S Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Soren Riis Paludan, Thor G Theander, Morten Agertoug Nielsen, Ali Salanti, Adam Frederik Sander
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nature communications 12 (1) (2021)